First Time Loading...

Carmat SA
PAR:ALCAR

Watchlist Manager
Carmat SA Logo
Carmat SA
PAR:ALCAR
Watchlist
Price: 4.25 EUR 1.19%
Updated: May 14, 2024

Intrinsic Value

Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. [ Read More ]

The intrinsic value of one ALCAR stock under the Base Case scenario is 24.99 EUR. Compared to the current market price of 4.25 EUR, Carmat SA is Undervalued by 83%.

Key Points:
ALCAR Intrinsic Value
Base Case
24.99 EUR
Undervaluation 83%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Carmat SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ALCAR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Carmat SA

Provide an overview of the primary business activities
of Carmat SA.

What unique competitive advantages
does Carmat SA hold over its rivals?

What risks and challenges
does Carmat SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Carmat SA.

Provide P/S
for Carmat SA.

Provide P/E
for Carmat SA.

Provide P/OCF
for Carmat SA.

Provide P/FCFE
for Carmat SA.

Provide P/B
for Carmat SA.

Provide EV/S
for Carmat SA.

Provide EV/GP
for Carmat SA.

Provide EV/EBITDA
for Carmat SA.

Provide EV/EBIT
for Carmat SA.

Provide EV/OCF
for Carmat SA.

Provide EV/FCFF
for Carmat SA.

Provide EV/IC
for Carmat SA.

Show me price targets
for Carmat SA made by professional analysts.

What are the Revenue projections
for Carmat SA?

How accurate were the past Revenue estimates
for Carmat SA?

What are the Net Income projections
for Carmat SA?

How accurate were the past Net Income estimates
for Carmat SA?

What are the EPS projections
for Carmat SA?

How accurate were the past EPS estimates
for Carmat SA?

What are the EBIT projections
for Carmat SA?

How accurate were the past EBIT estimates
for Carmat SA?

Compare the revenue forecasts
for Carmat SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Carmat SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Carmat SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Carmat SA compared to its peers.

Compare the P/E ratios
of Carmat SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Carmat SA with its peers.

Analyze the financial leverage
of Carmat SA compared to its main competitors.

Show all profitability ratios
for Carmat SA.

Provide ROE
for Carmat SA.

Provide ROA
for Carmat SA.

Provide ROIC
for Carmat SA.

Provide ROCE
for Carmat SA.

Provide Gross Margin
for Carmat SA.

Provide Operating Margin
for Carmat SA.

Provide Net Margin
for Carmat SA.

Provide FCF Margin
for Carmat SA.

Show all solvency ratios
for Carmat SA.

Provide D/E Ratio
for Carmat SA.

Provide D/A Ratio
for Carmat SA.

Provide Interest Coverage Ratio
for Carmat SA.

Provide Altman Z-Score Ratio
for Carmat SA.

Provide Quick Ratio
for Carmat SA.

Provide Current Ratio
for Carmat SA.

Provide Cash Ratio
for Carmat SA.

What is the historical Revenue growth
over the last 5 years for Carmat SA?

What is the historical Net Income growth
over the last 5 years for Carmat SA?

What is the current Free Cash Flow
of Carmat SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Carmat SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Carmat SA

Current Assets 42.4m
Cash & Short-Term Investments 8m
Receivables 5.1m
Other Current Assets 29.3m
Non-Current Assets 10.6m
Long-Term Investments 613k
PP&E 10m
Other Non-Current Assets 71k
Current Liabilities 15.6m
Accounts Payable 9.6m
Accrued Liabilities 5.9m
Other Current Liabilities 18k
Non-Current Liabilities 64.5m
Long-Term Debt 57.6m
Other Non-Current Liabilities 6.8m
Efficiency

Earnings Waterfall
Carmat SA

Revenue
2.8m EUR
Cost of Revenue
-33.8m EUR
Gross Profit
-31m EUR
Operating Expenses
-21.5m EUR
Operating Income
-52.5m EUR
Other Expenses
-1.3m EUR
Net Income
-53.9m EUR

Free Cash Flow Analysis
Carmat SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ALCAR Profitability Score
Profitability Due Diligence

Carmat SA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Exceptional ROE
Exceptional 1-Year Revenue Growth
ROE is Increasing
31/100
Profitability
Score

Carmat SA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

ALCAR Solvency Score
Solvency Due Diligence

Carmat SA's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
44/100
Solvency
Score

Carmat SA's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALCAR Price Targets Summary
Carmat SA

Wall Street analysts forecast ALCAR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALCAR is 14.13 EUR with a low forecast of 9.09 EUR and a high forecast of 18.9 EUR.

Lowest
Price Target
9.09 EUR
114% Upside
Average
Price Target
14.13 EUR
232% Upside
Highest
Price Target
18.9 EUR
345% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

ALCAR Price
Carmat SA

1M 1M
+10%
6M 6M
-8%
1Y 1Y
-44%
3Y 3Y
-82%
5Y 5Y
-79%
10Y 10Y
-95%
Annual Price Range
4.25
52w Low
2.9
52w High
7.96
Price Metrics
Average Annual Return -7%
Standard Deviation of Annual Returns 45.77%
Max Drawdown -92%
Shares Statistics
Market Capitalization 123.9m EUR
Shares Outstanding 29 142 400
Percentage of Shares Shorted
N/A

ALCAR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Carmat SA Logo
Carmat SA

Country

France

Industry

Health Care

Market Cap

123.9m EUR

Dividend Yield

0%

Description

Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 160 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels and Blood Institute, Laboratoire de Recherche Biochirurgicale and others. As of December 31, 2011, a company MATRA DEFENSE held a 30.57% stake in the Company’s shareholdings.

Contact

ILE-DE-FRANCE
Velizy-Villacoublay
36, avenue de l'Europe, Immeuble l'Etendard
+33139456450.0
http://www.carmatsa.com/

IPO

2010-07-07

Employees

160

Officers

CEO & Director
Mr. Stephane Piat
CFO & Head of investor relations
Ms. Pascale d'Arbonneau
Human Resources Director
Ms. Raouia Bouyanzer
Chief Medical Officer
Dr. Petrus Jansen

See Also

Discover More
What is the Intrinsic Value of one ALCAR stock?

The intrinsic value of one ALCAR stock under the Base Case scenario is 24.99 EUR.

Is ALCAR stock undervalued or overvalued?

Compared to the current market price of 4.25 EUR, Carmat SA is Undervalued by 83%.